Jonathan R. Green
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Bone health and treatments, Radiopharmaceutical Chemistry and Applications, Bone health and osteoporosis research, Bone Metabolism and Diseases, Medical Imaging Techniques and Applications
Most-Cited Works
- → Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid(2002)846 cited
- → Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound(1994)420 cited
- → Bisphosphonates: Preclinical Review(2004)400 cited
- → Highly Potent Geminal Bisphosphonates. From Pamidronate Disodium (Aredia) to Zoledronic Acid (Zometa)(2002)312 cited
- → Antitumor effects of bisphosphonates(2003)311 cited
- → Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs(2006)223 cited
- → Bisphosphonates: new therapeutic agents for the treatment of bone tumors(2004)132 cited
- → Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen‐induced arthritis(2004)126 cited
- → Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery(2010)123 cited
- → The bisphosphonate zoledronic acid has antimyeloma activityin vivoby inhibition of protein prenylation(2009)122 cited